Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when XENE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsXenon expands new-hire equity pool by 31% to 1.18M shares
Filed April 13, 2026 · Period ending April 7, 2026 · ~1 min read
Key Changes
-
medium
Item 5.02 verify on EDGAR →
Summary
Xenon Pharmaceuticals expanded its 2025 Inducement Equity Plan by 275,000 shares, bringing the total reserve to 1,175,000 shares. This plan is used exclusively to grant equity awards to new hires or employees returning after a break, serving as a material inducement to join the company.
The 31% increase suggests Xenon anticipates significant hiring in the near term and needs additional equity capacity to compete for talent. For retail holders, this is a routine governance matter with no immediate red flags. The plan operates under Nasdaq rules that permit inducement grants without shareholder approval, and the expansion reflects normal growth-stage biotech staffing needs.
The dilution is modest relative to typical equity compensation programs. Watch for hiring announcements or organizational expansion that would explain the increased capacity.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On April 7, 2026, Xenon Pharmaceuticals Inc. (the “Company”) amended and restated the Company’s Amended and Restated 2025 Inducement Equity Incentive Plan (as amended and restated, the “2025 Inducement Plan”) to increase the maximum number of shares of its common stock reserved for issuance under the 2025 Inducement Plan from 900,000 shares to 1,175,000 shares (subject to adjustments as provided in the 2025 Inducement Plan) to be used exclusively for grants of nonstatutory stock options, stock appreciation rights, restricted stock units, restricted stock, and performance awards as an inducement material to individuals being hired, or rehired following a bona fide period of interruption of employment, as an employee of the Company or any of its subsidiaries.
The company expanded its inducement equity plan by 275,000 shares (from 900,000 to 1,175,000), a 30.6% increase. This plan is used exclusively to grant equity awards to new hires or rehires as a material inducement to join the company. The expansion suggests the company anticipates significant hiring activity and needs additional equity capacity to attract talent. Under Nasdaq rules, inducement plans do not require shareholder approval.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify